Prideapplication/xmlftp://ftp.pride.ebi.ac.uk/pride/data/archive/2024/06/PXD045808/checksum.txtftp://ftp.pride.ebi.ac.uk/pride/data/archive/2024/06/PXD045808/20200123_CO_0912MoOl_Trypsin_TiO2_R03_1.rawftp://ftp.pride.ebi.ac.uk/pride/data/archive/2024/06/PXD045808/20200123_CO_0912MoOl_LysC_TiO2_R02_2.rawftp://ftp.pride.ebi.ac.uk/pride/data/archive/2024/06/PXD045808/20200123_CO_0912MoOl_Trypsin_TiO2_R03_2.rawftp://ftp.pride.ebi.ac.uk/pride/data/archive/2024/06/PXD045808/20200123_CO_0912MoOl_Trypsin_direct_R03_1.rawftp://ftp.pride.ebi.ac.uk/pride/data/archive/2024/06/PXD045808/20200123_CO_0912MoOl_Trypsin_direct_R03_2.rawftp://ftp.pride.ebi.ac.uk/pride/data/archive/2024/06/PXD045808/20200123_CO_0912MoOl_LysC_direct_R02_1.rawftp://ftp.pride.ebi.ac.uk/pride/data/archive/2024/06/PXD045808/20200123_CO_0912MoOl_LysC_TiO2_R02_1.rawftp://ftp.pride.ebi.ac.uk/pride/data/archive/2024/06/PXD045808/search.zipprimaryOK200monilola.olayioye@izi.uni-stuttgart.deMirita Franz-WachtelAffinity purification coupled with mass spectrometry proteomicsMass SpectrometryPolybasic regionGtpase activating proteinMembrane bindingRho signalingCytokinesishttps://www.ebi.ac.uk/pride/archive/projects/PXD045808Embryonic Kidney Cell LineFlag-tagged proteins were immunoprecipitated from cell, and proteins were digested on beads with LysC or trypsin and further purified via PHOENIX Peptide Cleanup Kit according to user manual. Phosphopeptide enrichment was done using TiO2 beads. Beads were resuspended in 80% ACN, 1% TFA, 3% 2,5-dihydroxybenzoic acid and incubated for 20 min. After its removal 90% of purified peptides dissolved in 80% acetonitrile (ACN)/6% trifluoroacetic acid (TFA) were added to Ti02 beads and incubated for 10 min. Bound and washed phosphopeptides were eluted from the beads with 5% NH4OH in 60% ACN in a first step, and with 80% ACN/1% formic acid (FA) in a second round. Pooled eluates were purified by C18 StageTips. Peptides were subjected to two consecutive rounds of enrichment. Peptides and enriched phosphopeptides were analysed on an EasyLC coupled to a QExactive HF mass spectrometer using a 57 minute segmented gradient of 10-33-50-90% of HPLC solvent B (80% ACN in 0.1% FA) in HPLC solvent A (0.1% FA) at a flow rate of 200 nl/min. Precursor ions were acquired in the mass range from m/z 200 to 1650 in the Orbitrap mass analyzer at a resolution of 60,000 (fill time 25 ms, AGC target 3x106). In each scan cycle, the seven most intense precursor ions were sequentially fragmented using higher energy collisional dissociation (HCD) fragmentation. In all measurements, sequenced precursor masses were excluded from further selection for 30 s. MS/MS scans were acquired with a resolution of 60,000 (fill time 220 ms, AGC target 105).PrideNot availableMS spectra were processed with MaxQuant software package version 1.5.2.8 with integrated Andromeda search engin. Database search was performed against a homo sapiens database obtained from Uniprot, containing 96,817 protein entries, the sequence of FLAG-DLC3 and 284 commonly observed contaminants. Endoprotease LysC and trypsin, respectively were defined as proteases with a maximum of three missed cleavages. The minimum peptide length was set to five. Oxidation of methionine, phosphorylation on serine, threonine and tyrosine, methylation on lysine and arginine, and N-terminal acetylation were specified as variable modifications, whereas carbamidomethylation of cysteine was set as fixed modification. Initial maximum allowed mass tolerance was set to 4.5 parts per million (ppm) for precursor ions and 20 ppm for fragment ions. Peptide, protein and modification site identifications were reported at a false discovery rate of 0.01, estimated by the target-decoy approach.ProteomicsMonilola A. OlayioyeUniversity of Stuttgart, Institute of Cell Biology and Immunology, Stuttgart, GermanyPARTIALHomo Sapiens (human)Not availablemirita.franz@uni-tuebingen.deProteome Center TuebingenGermanysodium salt, Rps17, ammonium formate, 13C-labeled, MeCN, cadmium salt, NCMe, ion, selection process, TFA, fond, Longterm., zinc formate, RPS17, gentisic acid, lead salt, Xkl-1, magnesium formate, CycEI, zinc salt, heavy chain disease, Solvent, Long Term, dmTAF[[II]]230, peptide, Trifluoroacetate, M(3)67, Polypeptides, KL receptor activity, M(3L)i, Gsfsco1, ammonium tetraformate, peptido, Ccne, BANF, cobalt(II) formate dihydrate, CH3-C#N, GRP1, Grp1, B1, High Performance Liquid Chromatography, SCO5, 2, Min, SCO1, 5-dihydroxybenzoate, Gsfsow3, rounded, Gsfsco5, Effect, WMS, DmelCG42273, SOW3, 3-hydroxy-5-estrane-17-carbonitrile, C79325, TFIID TAF250, peptides, cel, M, 2610036I19Rik, PTPSTEP, l(3)67BDo, 2610510L13Rik, min, mAPC, analyzer, W, copper, SCAN, HPLC, AI047805, fSAP152, lithium salt, High-Performance, ACN, l(2)k08110, Acn, trifluoro-, D1, Chromatography, Bs, TF, High-Performance Liquid, s, High Speed Liquid, D9, Sl, GPHYSD2, M(3)RpS17, ammonium (2:1) salt, Long-Term Effects, GPH, nickel salt, SGS, lithium 2, dTAF[[II]]230, cobalt (+2) salt, Liquid Chromatography, TAF200, Dmel_CG7826, M(3)67C, Longterm Effect, Tr-kit, Th, TAFII-250, TAF250/230, Cyc E, br37, not genetically inherited, fragmented, ACMICD, PBT, TAFII250, sodium (4:1:1) salt, BG:DS07108.3, HCD, Dm1, magnesium salt, Ionen, M(3)i(55), 3.1.3.48, kl1-A, KIT, nickel (+2) salt, l(2)05206, Dmel_CG7835, Acetic acid, Mnb, MNB, parent ion, tyrosine-protein kinase Kit, rpS17, Acid, pbt, ammonium salt, Step, CG11628, MS/MS, cracked, Rp S17, Trifluoroacetic, formate, cobaltous formate, pooled, cromium (+3), Striatum-enriched protein-tyrosine phosphatase, kit, MASS, AW124434, CG17603, TAF[[II]], beta Trypsin, monosodium salt, l35Dd, precursor ion, Taf250, Cesium, STEP, SR3-5, copper salt, ammonium (4:1) salt, Liquid, Polypeptide, methyl cyanide, lead (+2) salt, TAF230, krk1, d230, GRP1/cytohesin 1, nickel formate dihydrate, cycline, lead formate, Effects, fractured, DmcyclinE, aluminum salt, cesium salt, SCF receptor activity, FBN, Gene, dTAFII250, cycE, ACINUS, precursor, thomson, EfW1, 17alpha)-isomer, l(2)br37, CG7826, CYCLE, formic acid, mass-to-charge ratio, CG11633, cdi7, cytohesin/GRP1, potassium salt, M(3)S33, M(3)i, cyclinE, scfr, dmTAF1, Taf230, ECTOL1, 14C-labeled, Gene Products, CG7835, Cdi7, CDI7, CG42273, SCFR, TAF250, Cesium Trifluoroacetate, Taf200, Fdc, dTAF[[II]]250, CYCE, Acinus, thallium (+1) salt, Longterm, cell, iones, DmelCG3938, MS2, CyclE, beta-Trypsin, rubidium salt, l(2)SH2 0323, 3938, Minute, Taf1p, Long-Term, calcium formate, methanoic acid, l(3)dtOA4, DmcycE, ions, High-Performance Liquid Chromatographies, acinusL, OCTD, l(2)k05007, dTAF250, dm-cycE, Neural-specific protein-tyrosine phosphatase, DmelCG3922, acinusS, M(3)i[55], Ultra Performance Liquid Chromatography, peptidos, cromium (+3) salt, Long-Term Effect, UPLC, TAF, sodium formate, PTHB1, High-Performance Liquid Chromatography, proto-oncogene c-Kit, DYRK1, TAF[[II]]250, 1-(14)C-labeled, nickel formate, 3H-labeled, Proteins, strontium formate, split, l(3)84Ab, stepk, BG:DS00004.13, potassium formate, copper (+2) salt, acetonitrile, strontium salt, Cell, Peptide, mKIAA0670, dTAF230, CD142, polypeptide, Phosphopeptide, l(2)k02514, DmCycE, KIT ligand receptor activity, C18, p230, cupric formate, Protein, Long Term Effects, hemorrhaged, TAF[[II]]250/230, TFIID, 5alpha, BcDNA:RE44119, MFS1, Dyrk1, CyeE, (3alpha, aluminum formate, l(2)SH0323, ACETONITRILE, tandem MS, cyanomethane, WMS2, XKrk1, CYH1, Taf[[II]]250, AU020952, torn, c-KIT, lithium formate, TAF[[II]]230, PRSS, l(2)k02602, CC1, M(3)q, l(2)35Dd, Tripcellim, TAF[II]250, ethanenitrile, CD117, anon-EST:Posey48, chromic formate, DmelCG11628, Longterm Effects, ME-IV, CG3922, Protein Gene Products, Gene Proteins, Trypure, D-CycE, c-kit, High Pressure, DmelCG17603, C-Kit, Ion, Ssm, SSKS, xkl-1, calcium salt, M(3L)i[55], Peptid, round, High Performance Liquid, 5-dihydroxybenzoic acid, SCH, CG3938, TAF1, 3-OHECNSocial, Regulations, cell cycle regulator, STARTGAP3, Social Control, Formal Social Control, ARHGAP38, Control, regulation, tumor suppressor., DLC3, Dlc3, Controls, Regulation, mKIAA0189, Formal Social Controls, Social ControlsIPP2A2, para Tyrosine, ion, Lysine Hydrochloride, DL-Arginine Acetate, Monohydrate, L-Threonine, protein, phosphorylation, 2-Amino-3-hydroxypropionic acid, 5730420M11Rik, peptide, Polypeptides, L-Isomer Methionine, Lysine Acetate, Methionine, peptido, 2, Software Engineering, Arg, protein aggregate, Computer Program, WMS, Threonin, L Lysine, SET, (S)-2-amino-5-guanidinopentanoic acid, Man (Taxonomy), STARTGAP3, peptides, TAF-I, K, M, Open, 2-amino-3-(4-hydroxyphenyl)propanoic acid, 3-(p-Hydroxyphenyl)alanine, (S)-2-Amino-5-guanidinovaleric acid, R, Computer Programs and Programming, epsilon-diaminocaproic acid, Arginine, Monohydrate DL-Arginine Acetate, Y, DmelCG4299, IGAAD, set, LYS, 2-amino-3-hydroxypropanoic acid, DmelCG10574, Tyr, Lysin, ppm, Half Cystine, GPHYSD2, Racemethionine, SGS, L-Arginin, phapii, Zinc Cysteinate, T5E21.12, Modern, acetylation, 2-Amino-4-(methylthio)butyric acid, 2-Amino-3-(p-hydroxyphenyl)propionic acid, Arginine Hydrochloride, StF-IT-1, arginine, para-Tyrosine, Arginin, Source Softwares, Software Tools, Programs, Tyrosine, ACMICD, Program, Computer Applications, 3-Hydroxyalanine, Ionen, Computer Applications Software, Computer Applications Softwares, lysine, Methionin, Softwares, Hmet, region, L-Arginine, parent ion, Software Applications, HLA-DR-associated protein II, DI-2, Source Software, I-2Dm, L-isomer, L-Cysteine, CG4299, alpha, MASS, beta Trypsin, human, L isomer, I-2PP1, Applications, TAF-IBETA, precursor ion, L Serine, TAF-Ibeta, L-Tyrosine, Polypeptide, DLC3, Dlc3, L-Serine, i2pp2a, Liquimeth, Computer Software Applications, human being, 2-amino-4-(methylsulfanyl)butanoic acid, Cysteine Hydrochloride, ARHGAP38, L Isomer, 2-Amino-5-guanidinovaleric acid, FBN, Gene, Computer, precursor, protein-containing complex, PHAPII, Human, L-(+)-arginine, Homo sapiens, (2S)-2-amino-5-(carbamimidamido)pentanoic acid, ECTOL1, Harg, Gene Products, L-Methionine, Lysine, Half-Cystine, Man, Pedameth, Application, Open Source Softwares, Software Application, L Cysteine, iones, ipp2a2, beta-Trypsin, Open Source Software, Acetylations, 2pp2a, L Threonine, ions, man, CG10574, Computer Software Application, OCTD, T5E21_12., 2PP2A, 2-amino-4-(methylthio)butanoic acid, Tools, 10^[-6], L Tyrosine, taf-ibeta, dSET, dSet, L-Arg, site, peptidos, Tyrosin, metionina, mKIAA0189, Methylations, 2-amino-5-(carbamimidamido)pentanoic acid, Applications Software, Open Source, Computer Software, DL-Methionine, protein complex, Proteins, igaad, Phosphorylations, 2-amino-5-guanidinopentanoic acid, L-Isomer, DL Arginine Acetate, Peptide, Tool, group, polypeptide, Serin, Software Tool, native protein, I-2PP2A, tirosina, L-Isomer Arginine, Acetate, Protein, Dm I-2, I2PP2A, Hydrochloride, sequence, MFS1, L Arginine, methylation, Software, L-Lysine, Data Base, Met, WMS2, PRSS, ensemble, (2S)-2-amino-5-guanidinopentanoic acid, Engineering, Tripcellim, primary structure of sequence macromolecule, Protein Gene Products, Computer Programs, Gene Proteins, Trypure, dSET/TAF-Ibeta, 2610030F17Rik, Applications Softwares, Ion, Modern Man, SSKS, alpha-amino-gamma-methylmercaptobutyric acid, Peptid, variable, AA407739, 6-diaminohexanoic acid, Enisyldlmo, Plasma Membranes, Activity, primary tumour of the liver, DLMO, protein sorting along secretory pathway, Sequence Determination, Rho A, Phases, adult hepatoma, hepatic, hepatocellular carcinoma plus intrahepatic cholangiocarcinoma, phosphorylation, Divisions, primary liver cancer, prevention, hdp-a, Mutations, Membrane Tissues, dLmo, dLMO, DmelCG1004, Roles, vesicle transport, rho-1, Associations, Concepts, DRho, establishment and maintenance of substrate location, D-p190, Analysis, AAF01186, prevention and control, 8416, mdrc, 46H23.2, not specified as primary or secondary, DLC-2, Dmrho, Hepatic Cancer, M Phases, STARTGAP3, reference sample, Analyses, Determination, M, membrane region, Tissue, DMRHO, adult primary hepatocellular carcinoma, IBP, hepatic cancer, Sequence Determinations, rhoA, RHO1, Rho1, inner endospore membrane, DmelCG8416, Division Phase, preventive measures, Bd, plasma membrane lipid bilayer, geographical area, Dlmo, plasmalemma, rho1, Role Concepts, Plasma Membrane, Adherens Junction, Cancer of the Liver, fliH, ibp, hepatic neoplasm, BcDNA:GM05133, Deleted in liver cancer 2 protein, liver Cancer, Membrane Tissue, establishment and maintenance of substance location, Liver, preventive therapy, DmRHO-A, Rho-1, BZRP, RHOb, Cancer of Liver, primary cancer of liver, liver Cancers, HSC0013, CG1004, integral to membrane, Cell Divisions, Dm Rho1, Determinations, PBS, rhom, PBR, cellular membrane, single organism localization, Role Concept, RhoN19, Bzrp, RhoGAP P190, Liver Neoplasm, RhoA, ve, Role, RHOM, RhoM, bacterial inner membrane, p190RhoGAP, bzrp, RHOHP1, CG32555, Ptd, pbr, p50rhoGAP, nonselective vesicle transport, cell membrane, positional polypeptide feature, D-Rho1, AI326383, non-resectable primary hepatic malignant neoplasm, bzrp-a, Ve, CG8416, RHO, Rho, Junction, DMRHOa, DMRHOb, Adherens, neoplasm of liver, RhoGAP, CDC42GAP, rhomboid/veinlet, Hepatocellular Cancers, Lmo, LMO, Cancer of liver, ARHD, hdp, DLC3, Dlc3, rho, establishment and maintenance of cellular component location, BPBS, Dmelrho, NEOPL LIVER, resectable malignant neoplasm of the liver, DRORHO, ARHGAP38, region or site annotation, CG8240, Neoplasms, Cytoplasmic Membrane, Arhd, Hepatic Neoplasm, Rho GTPase, 8267, liver, DRhoA, dttg, integral component of membrane, establishment and maintenance of position, cell-cell adherens junction, RHOGAP, CG6500, primary, vesicle trafficking, dRhoA, positional, beadex/dLMO, Cell Division Phase, Liver Cancer, primary malignant neoplasm of Liver, Tissues, Cancer of the liver, General activity., Liver Cancers, Hepatic Neoplasms, pk18, Cell Division, malignant neoplasm of liver, RhoGAP-16B12, DRho1, Division, MBR, Junctions, Rho GTPase-activating protein, DrhoA, OPN2, Cytoplasmic, ptbr, malignant hepato-biliary neoplasm, Resectable malignant neoplasm of Liver, primary malignant neoplasm of liver, rhoGAP, RhoHP1, Cytoplasmic Membranes, Drho1, region of membrane, START domain-containing protein 13, PTBR, Hepatic, dRho1, mKIAA0189, integral to plasma membrane, mbr, Controlled, Cancer, Sequence Analyses, DmelCG6500, RHOGAP1, DRhoGAP, membrane, Rho kinase, Controlling, Characters, Hepatic Cancers, DBI, primary tumor of the liver, l(2)52Fa, integral component of plasma membrane, iks, Phosphorylations, l(2)k02107b, Cell, vesicular transport, Concept, Zonula Adherens, PKBS, dbi, Sequence, Neoplasm, whole membrane, DmelCG32555, sequence, establishment and maintenance of localization, Zonula, pkbs, Cell Membranes, M Phase, dnRho, Plasma, Membranes, Phase, ca liver - primary, transmembrane, Tspo1, CG8267, distinct, prophylaxis, E3.10/J3.8, Cancers, single-organism localization, malignant tumor of liver, Membrane, mDRC, primary structure of sequence macromolecule, hld, StARD13, localisation, Ca liver - primary, control, Hepatocellular, LIVER NEOPL, BcDNA:GH17919, p190 RhoGAP, p190-RhoGAP, cytoplasmic membrane, n(2)k07236, Hepatocellular Cancer, General activityfalseRegulation of the DLC3 tumor suppressor by a novel phosphoswitchDeleted in Liver Cancer 3 (DLC3) is a Rho GTPase-activating protein (RhoGAP) that plays a crucial role in maintaining adherens junction integrity and coordinating polarized vesicle transport by modulating Rho activity at the plasma membrane and endomembranes. By employing bioinformatical sequence analysis, in vitro experiments, and in cellulo assays a polybasic region (PBR) responsible for mediating the association of DLC3 with cellular membranes was identified. It was shown that the DLC3 PBR contains two novel phosphorylation sites that can alter the local electrostatic character of the PBR and its ability to interact with negatively charged membranes. Accordingly, upon introduction of phosphomimetic mutations into the DLC3 PBR, membrane association of DLC3 was impaired. Furthermore, we uncovered a distinct, PBR-dependent localization of DLC3 at the midbody during cell division, where it exerted control over local Rho activity.2024-06-042023-09-29PXD045808NEWT:330879NEWT:377960NEWT:2042546NEWT:259447NEWT:295546NCBITaxon:2719036NCBITaxon:1280NEWT:112503NEWT:1129NEWT:309807NEWT:59753NEWT:89184NEWT:309800NEWT:281395NEWT:1211601NEWT:876138NEWT:44271NEWT:193516NEWT:1073882NEWT:475174NEWT:111205NEWT:1117NEWT:498257NEWT:10036NEWT:1590NEWT:10034NEWT:661410NEWT:638632NEWT:224326NEWT:376619NCBITaxon:79857NEWT:1096976NEWT:1589NEWT:135622NEWT:35786NEWT:1580NEWT:399784NEWT:96731NEWT:383379NEWT:418106NEWT:10029NEWT:913645NEWT:641809NEWT:38815NEWT:317447NEWT:4688NEWT:111225NEWT:7719NEWT:868565NEWT:135674NEWT:79329NEWT:30069NEWT:12637NEWT:59729NEWT:2164133NEWT:295105NEWT:108061NEWT:60711NEWT:224308NEWT:3347NEWT:160621NEWT:212790NEWT:110368NEWT:1310161NEWT:77133NEWT:145481NEWT:1310165NEWT:29058NCBITaxon:79824NEWT:1912919NEWT:44688NEWT:44689NEWT:498211NEWT:347256NEWT:5518NEWT:398007NEWT:1527468NEWT:498217NEWT:498216NEWT:11320NEWT:246196NEWT:246197NEWT:145458NEWT:44685NEWT:161934NEWT:1148NEWT:5508NEWT:3329NEWT:419481NEWT:5507NEWT:410661NEWT:1140NCBITaxon:2157NEWT:1143NEWT:1287689NEWT:1094343NEWT:1462472NEWT:1336795NEWT:644042NEWT:1182590NEWT:3712NEWT:3711NEWT:270643NEWT:2065263NEWT:177437NEWT:10418NEWT:118698NEWT:1616117NEWT:118696NEWT:34865NEWT:52283NEWT:284812NEWT:8175NEWT:43330NEWT:1603293NEWT:44664NEWT:43346NEWT:3702NEWT:1245466NEWT:244366NEWT:1246791NEWT:118694NEWT:2850NEWT:118691NEWT:34871NEWT:33548NEWT:52299NEWT:96794NEWT:3708NEWT:332648NEWT:44670NEWT:536231NEWT:376219NEWT:219813NEWT:1510NEWT:460519NEWT:1515NEWT:572307NEWT:1432138NEWT:1424507NEWT:1194599NEWT:272844NEWT:1303443NEWT:9483NEWT:485NEWT:56636NEWT:2709072NEWT:2853422NEWT:1679718NEWT:480NEWT:67767NEWT:46835NEWT:109757NEWT:582580NEWT:1185650NEWT:216778NEWT:294607NEWT:1502NEWT:128017NEWT:376686NEWT:95486NEWT:1883446NEWT:1233435NEWT:109760NEWT:29031NEWT:317047NEWT:460523NEWT:235443NEWT:1757312NEWT:85694NEWT:108458NEWT:5936NEWT:320637NEWT:1078283NEWT:3750NEWT:983964NEWT:11706NEWT:32644NEWT:527796NEWT:499175NEWT:109779NEWT:3745NEWT:1715989NCBITaxon:4751NEWT:3747NEWT:1116234NEWT:1255228NEWT:410289NEWT:373153NEWT:472NEWT:940825NEWT:529507NEWT:1071661NEWT:470NEWT:5911NCBITaxon:50557NEWT:39251NEWT:29491NEWT:101841NEWT:446NEWT:153481NEWT:2014887NEWT:33952NEWT:445NEWT:153009NEWT:261756NEWT:166313NEWT:63366NEWT:63367NEWT:215402NEWT:1547NEWT:906914NEWT:9031NEWT:27292NEWT:1050722NEWT:108931NEWT:1293497NEWT:1055524NEWT:150475NEWT:267872NEWT:172269NEWT:9534NEWT:5180NEWT:256737NEWT:9541NEWT:8694NEWT:33936NEWT:8692NEWT:2903NEWT:185579NEWT:13076NEWT:1006581NEWT:8673NEWT:33940NEWT:550NEWT:554NEWT:451516NEWT:552NEWT:1325291NEWT:36185NEWT:1054211NEWT:1225786NEWT:51338NEWT:575412NEWT:28112NEWT:6493NEWT:6494NEWT:6491NEWT:507601NEWT:520NEWT:186441NEWT:643680NEWT:214092NCBITaxon:6157NEWT:13095NEWT:162425NEWT:104105NEWT:216257NEWT:9986NEWT:8654NEWT:8658NEWT:1268063NEWT:8657NEWT:8655NEWT:5147NEWT:28108NEWT:28104NEWT:407821NEWT:568703NCBITaxon:2NEWT:568708NEWT:986NEWT:52641NEWT:28532NEWT:353152NEWT:298176NEWT:40674NEWT:1194669NEWT:51329NEWT:443906NEWT:519NEWT:2510939NEWT:7394NEWT:6063NEWT:1328388NEWT:1548728NEWT:667127NEWT:9557NEWT:377586NEWT:300641NEWT:39655NEWT:9554NEWT:38323NEWT:256318NEWT:206411NCBITaxon:6191NEWT:229533NEWT:214053NEWT:80863NEWT:90675NEWT:52638NEWT:57075NEWT:1666905NEWT:8697NEWT:8695NEWT:884204NEWT:1123869NEWT:9544NEWT:9545NEWT:979NEWT:7370NEWT:83906NEWT:99488NEWT:1134506NEWT:255470NEWT:38783NEWT:6426NEWT:33090NEWT:9935NEWT:287889NEWT:305959NEWT:13489NEWT:29829NEWT:92867NEWT:92866NCBITaxon:3055NEWT:51750NEWT:202950NEWT:295027NCBITaxon:11320NEWT:632957NEWT:9925NCBITaxon:9606NEWT:90690NEWT:1436183NEWT:300273NEWT:4232NEWT:416348NEWT:11298NEWT:4236NEWT:7742NEWT:196627NEWT:200308NEWT:200302NEWT:870435NEWT:9913NEWT:9915NEWT:105841NEWT:2666255NEWT:999810NCBITaxon:5693NEWT:28995NEWT:1392998NEWT:380394NEWT:226900NEWT:1266738NEWT:231490NEWT:244704NEWT:7725NEWT:9909NEWT:9902NEWT:430615NEWT:563041NEWT:72664NEWT:36599NEWT:41949NEWT:326423NEWT:452467NEWT:198822NEWT:36111NEWT:326424NEWT:1678078NEWT:749906NEWT:418985NEWT:749907NEWT:150847NEWT:29835NEWT:431947NEWT:69014NEWT:142809NEWT:302409NEWT:130821NEWT:27606NEWT:1519788NEWT:59202NEWT:9975NEWT:8643NEWT:1159899NEWT:502780NEWT:860688NEWT:13443NEWT:35231NEWT:8644NEWT:5141NEWT:46360NCBITaxon:3044782NEWT:202914NEWT:160235NEWT:502779NEWT:297246NEWT:8639NEWT:1928434NEWT:8637NEWT:1114970NEWT:2096NEWT:192222NEWT:9963NEWT:1617910NEWT:637379NEWT:2785785NEWT:411901NEWT:1298722NEWT:8626NEWT:186801NEWT:105884NCBITaxon:9615NEWT:8621NEWT:58334NEWT:58331NEWT:8624NEWT:5116NEWT:8623NEWT:5597NCBITaxon:3077NEWT:194439NCBITaxon:12637NEWT:38727NEWT:218496NEWT:8618NEWT:70448NEWT:300251NEWT:9940NEWT:1247190NEWT:118702NEWT:118700NEWT:2126719NEWT:118705NEWT:6945NEWT:2104NEWT:2627626NEWT:6943NEWT:157546NEWT:870726NEWT:91374NEWT:91373NEWT:474186NEWT:54195NEWT:10136NEWT:38942NEWT:4762NEWT:6941NEWT:307972NEWT:2102NEWT:34NEWT:38949NEWT:1299114NEWT:1590841NEWT:1276473NEWT:2282334NEWT:1247NEWT:70667NEWT:869728NEWT:6938NCBITaxon:39054NEWT:1736309NEWT:4751NEWT:194963NEWT:15819NEWT:109461NEWT:1085956NEWT:6928NEWT:1239NEWT:36745NEWT:400727NEWT:272563NEWT:11009NEWT:913998NEWT:68335NEWT:3885NEWT:3888NEWT:649408NEWT:6915NEWT:101510NEWT:3880NEWT:272559NEWT:216816NEWT:153151NEWT:515849NEWT:10141NEWT:95767NEWT:466585NEWT:1000589NEWT:85963NEWT:29NEWT:85962NEWT:42197NEWT:143361NEWT:1299NEWT:424718NEWT:316407NEWT:1794699NCBITaxon:183674NEWT:167387NEWT:84645NEWT:1123294NEWT:209285NEWT:211586NEWT:747078NEWT:1282NEWT:1283NEWT:1000561NEWT:2133NEWT:294381NEWT:197NEWT:1390363NEWT:35889NEWT:406072NEWT:1454958NEWT:29176NEWT:1073569NEWT:4787NEWT:751585NEWT:113549NEWT:180788NEWT:159749NEWT:1270NEWT:388919NEWT:4784NEWT:360106NEWT:4785NEWT:360104NEWT:10117NEWT:401614NEWT:10116NEWT:1280NEWT:83333NEWT:83334NEWT:242718NEWT:83332NEWT:242715NEWT:100226NEWT:1263NEWT:176299NEWT:54126NEWT:75058NEWT:13616NEWT:13613NEWT:172NEWT:296543NEWT:173NEWT:316435NEWT:42157NEWT:1034304NEWT:105023NEWT:866628NEWT:535026NEWT:749200NEWT:272943NEWT:145953NEWT:257309NEWT:203124NEWT:306254NEWT:230741NEWT:8296NEWT:117008NEWT:167748NEWT:1163394NEWT:645463NEWT:990119NEWT:77216NEWT:1111708NEWT:998086NEWT:493760NEWT:93163NEWT:257313NEWT:3827NEWT:400772NEWT:128161NEWT:930945NEWT:332521NEWT:106350NEWT:269796NEWT:54571NEWT:412754NEWT:9598NEWT:1423772NEWT:51056NEWT:53232NEWT:1235987NCBITaxon:2509511NEWT:1639NEWT:188229NEWT:3818NEWT:432359NEWT:9103NEWT:715877NEWT:862238NEWT:29159NEWT:1155748NEWT:9593NEWT:9595NEWT:246200NEWT:6087NEWT:145943NEWT:595536NEWT:1134822NEWT:240906NEWT:89920NEWT:29158NEWT:44744NEWT:3879NEWT:1328881NEWT:411483NEWT:76336NEWT:3870NEWT:884019NEWT:411490NEWT:169963NEWT:587NEWT:588NEWT:585NCBITaxon:43925NEWT:746128NEWT:212035NCBITaxon:1653394NEWT:1205NEWT:214693NEWT:45609NEWT:9172NEWT:2770979NEWT:1277351NEWT:1594786NEWT:3854NEWT:411469NEWT:1679NEWT:333849NEWT:214684NEWT:569NEWT:411464NEWT:411460NEWT:1328426NEWT:562NEWT:411470NEWT:2094720NCBITaxon:2697049NEWT:294750NEWT:1663NEWT:214675NEWT:62141NEWT:3848NEWT:3847NEWT:198466NEWT:327159NEWT:178876NEWT:1660NEWT:327160NEWT:573NEWT:571NEWT:142479NEWT:29595NEWT:241368NEWT:42528NEWT:1969471NEWT:264483NEWT:439733NEWT:76777NEWT:76773NEWT:1121114NEWT:663NEWT:1081927NEWT:1238993NEWT:67825NEWT:187878NEWT:1504802NEWT:1821314NEWT:1249668NEWT:426430NEWT:38033NEWT:37181NEWT:929439NEWT:9646NEWT:5286NEWT:7469NEWT:9644NEWT:426428NEWT:63459NEWT:2652157NEWT:2652158NEWT:1276815NEWT:40324NEWT:588858NEWT:9638NEWT:9639NCBITaxon:11071NEWT:693977NEWT:242231NEWT:197221NEWT:528354NEWT:51453NEWT:1279085NEWT:28231NEWT:7460NEWT:504457NEWT:392227NEWT:1004024NEWT:103372NEWT:862751NEWT:470150NEWT:9627NEWT:1009714NEWT:73239NEWT:38018NEWT:226186NEWT:381518NEWT:8782NEWT:30538NEWT:115357NEWT:63436NEWT:63433NEWT:13164NEWT:1601067NEWT:40302NEWT:2664179NEWT:623NEWT:7038NEWT:6192NCBITaxon:1639NEWT:3915NCBITaxon:3570232NEWT:405534NEWT:9689NEWT:8355NEWT:633NEWT:9685NEWT:7029NEWT:6182NEWT:9694NEWT:186990NEWT:8364NEWT:632NEWT:6183NEWT:1423800NEWT:630NCBITaxon:11019NEWT:334747NEWT:3907NEWT:3906NEWT:61235NEWT:343691NEWT:1457551NEWT:15368NEWT:1491466NEWT:340188NEWT:170187NEWT:1755437NEWT:1042399NEWT:1719NEWT:692672NEWT:2697049NEWT:1109443NEWT:58042NEWT:7004NEWT:9669NCBITaxon:6073NEWT:1089448NEWT:1329349NEWT:607699NEWT:6161NEWT:206542NEWT:27337NEWT:575584NEWT:186536NEWT:185687NEWT:3039NEWT:2706014NEWT:8727NEWT:8726NEWT:10090NEWT:8729NEWT:8720NEWT:5693NEWT:2186NEWT:8724NEWT:8723NEWT:283166NEWT:8722NEWT:5697NEWT:6544NEWT:218192NCBITaxon:10114NEWT:2190NEWT:1685931NEWT:242619NEWT:557723NEWT:557722NEWT:160791NEWT:1353008NEWT:34073NEWT:402042NEWT:373995NEWT:5689NEWT:8715NEWT:544404NEWT:287535NEWT:2173NEWT:2175NEWT:1232801NEWT:5691NEWT:61674NEWT:2072580NEWT:669465NEWT:1117957NEWT:6526NEWT:8709NEWT:1306274NEWT:5671NEWT:8700NEWT:1692259NEWT:1486917NEWT:2636997NEWT:1843183NEWT:5661NEWT:157592NEWT:51866NEWT:58002NEWT:13136NEWT:5665NEWT:1179777NEWT:6997NEWT:5666NEWT:5664NEWT:2157NEWT:70125NEWT:146479NEWT:1843192NEWT:206189NEWT:6108NEWT:1720309NEWT:9612NEWT:1286640NEWT:38865NEWT:3077NEWT:9615NEWT:6100NEWT:713604NEWT:3076NEWT:112273NEWT:33178NEWT:1147787NEWT:1440772NEWT:10040NEWT:8759NEWT:9605NEWT:9606NEWT:641501NEWT:9601NEWT:8756NEWT:74940NEWT:13551NEWT:10041NEWT:9600NEWT:1450511NEWT:439375NEWT:890382NEWT:174934NEWT:179392NEWT:2823525NEWT:115778NEWT:1538186NEWT:227086NEWT:3055NEWT:195883NEWT:1450520NEWT:1042311NEWT:1123352NEWT:29920NEWT:235909NEWT:47311NCBITaxon:813NEWT:127785NEWT:708248NEWT:104660NEWT:652611NEWT:8732NEWT:763037NEWT:3555NEWT:71647NEWT:260201NEWT:35554NCBITaxon:12939NEWT:32046NEWT:2222NEWT:544496NEWT:59529NEWT:32049NEWT:1392696NEWT:45351NEWT:445974NEWT:43179NEWT:180454NEWT:5722NEWT:10245NEWT:55153NEWT:351581NEWT:43186NEWT:428146NEWT:889247NEWT:498019NEWT:1351NEWT:1438992NEWT:1352NEWT:2649997NEWT:1147161NEWT:43150NEWT:263737NEWT:1333499NEWT:5702NEWT:95648NEWT:1349NEWT:67593NEWT:1401257NEWT:44491NEWT:27933NEWT:556484NEWT:7955NEWT:7959NEWT:2261NEWT:94323NEWT:31156NEWT:3112NEWT:8801NEWT:4442NEWT:192875NEWT:1214915NEWT:1214916NEWT:284218NEWT:1316931NEWT:511145NEWT:931281NEWT:4432NEWT:5762NEWT:5763NEWT:658457NEWT:35525NEWT:295358NEWT:2246NEWT:2652724NEWT:5757NEWT:68415NCBITaxon:4563NEWT:5755NEWT:44447NEWT:752555NEWT:5759NEWT:1736231NEWT:1392NEWT:35974NEWT:2242NEWT:1396NEWT:286NEWT:391619NEWT:287NEWT:1367269NEWT:633149NEWT:1149786NEWT:10239NEWT:68895NEWT:4897NEWT:5744NEWT:72901NEWT:213863NEWT:55571NEWT:35500NEWT:1235816NEWT:2041044NEWT:3562NEWT:4896NEWT:1262161NEWT:1314781NEWT:1390NEWT:11557NEWT:294NEWT:1773NEWT:82380NEWT:935293NEWT:375146NEWT:1772NEWT:263NEWT:11988NEWT:400667NEWT:408169NEWT:47946NEWT:459758NEWT:1764NEWT:243277NEWT:7067NEWT:586722NEWT:274NEWT:7070NCBITaxon:287NEWT:408172NEWT:408170NEWT:1436733NEWT:42229NEWT:1247411NEWT:9238NEWT:13708NEWT:333760NEWT:34607NEWT:1513458NEWT:1233681NCBITaxon:40559NEWT:506599NEWT:81077NEWT:84588NEWT:1279007NEWT:65349NEWT:300852NEWT:508771NEWT:1121405NEWT:253NCBITaxon:2759NEWT:93061NEWT:93062NEWT:34613NEWT:548470NCBITaxon:4932NEWT:1748NEWT:108673NEWT:943274NEWT:644223NEWT:1263082NEWT:272623NEWT:272624NEWT:886559NEWT:55521NEWT:118499NEWT:1130798NEWT:55529NEWT:256136NEWT:476272NEWT:195051NEWT:3988NEWT:561007NEWT:649908NEWT:3983NEWT:203696NEWT:352472NEWT:97441NEWT:1154756NEWT:1202531NEWT:1202532NEWT:360094NEWT:1408223NEWT:1408224NEWT:41364NEWT:1313NEWT:1218097NEWT:1080348NEWT:1314NEWT:39491NEWT:212142NCBITaxon:5811NEWT:1499105NEWT:192812NEWT:571256NEWT:40483NEWT:688333NCBITaxon:548681NEWT:318586NCBITaxon:5820NEWT:272634NEWT:198107NEWT:1979401NEWT:155892NEWT:167879NEWT:1872122NEWT:1308NEWT:7091NEWT:1034015NEWT:760568NEWT:141262NEWT:1813NEWT:4087NEWT:9778NEWT:306NEWT:303NEWT:97477NEWT:7111NEWT:113287NEWT:347515NEWT:6269NEWT:4090NEWT:4092NEWT:4093NEWT:4096NEWT:208895NEWT:941442NEWT:536088NEWT:311553NEWT:1226408NEWT:43984NEWT:7108NEWT:40479NEWT:43989NEWT:4076NEWT:142615NEWT:317NEWT:885318NEWT:39488NEWT:4081NEWT:273068NEWT:1316582NEWT:98334NEWT:231663NEWT:4084NEWT:63577NEWT:7574NEWT:1715256NEWT:30640NEWT:929793NEWT:1507179NEWT:29204NEWT:114155NEWT:1337056NEWT:634955NEWT:6239NEWT:102169NEWT:208893NEWT:4054NEWT:98351NEWT:1263854NEWT:118503NEWT:2059687NEWT:160488NEWT:63558NEWT:207559NEWT:107401NEWT:85057NEWT:985076NEWT:1215323NEWT:7159NEWT:267671NEWT:7160NEWT:8496NEWT:7165NEWT:1257118NEWT:1387333NEWT:27448NEWT:235612NEWT:243230NEWT:936053NEWT:1080772NEWT:8479NEWT:8485NEWT:119857NEWT:49240NEWT:391295NEWT:104395NEWT:93934NEWT:9315NEWT:6289NEWT:6287NEWT:38569NEWT:727NEWT:9796NEWT:118562NEWT:725NEWT:7137NEWT:469008NEWT:9321NEWT:596153NEWT:1836NCBITaxon:10298NEWT:105231NEWT:104385NEWT:74649NEWT:1037924NEWT:206672NEWT:9788NEWT:4097NEWT:71139NEWT:9785NEWT:6279NEWT:9793NCBITaxon:780NCBITaxon:1502NEWT:6282NEWT:27457NEWT:4006NEWT:1872635NCBITaxon:5476NEWT:113208NEWT:6669NEWT:1215360NEWT:89453NEWT:1114301NEWT:51515NEWT:13249NEWT:588596NEWT:51511NEWT:8845NEWT:7998NEWT:419610NEWT:5334NEWT:382352NEWT:413071NCBITaxon:10239NCBITaxon:714NEWT:11051NEWT:89462NEWT:452680NEWT:8839NEWT:2758385NEWT:171101NEWT:714NEWT:5322NEWT:421932NEWT:312017NEWT:576131NEWT:553470NEWT:284593NEWT:100392NEWT:655819NEWT:5315NEWT:11082NEWT:265872NEWT:337330NEWT:2285NEWT:2287NEWT:6645NEWT:981087NEWT:180066NEWT:46147NCBITaxon:6312NEWT:11072NEWT:174633NEWT:1416333NEWT:35024NEWT:135461NEWT:7962NEWT:99287NEWT:1817808NEWT:145262NEWT:145263NEWT:694569NEWT:9739NEWT:111069NEWT:1379791NEWT:51953NEWT:57267NEWT:3197NEWT:13686NEWT:2750454NEWT:1402135NEWT:36329NEWT:62615NEWT:1555636NEWT:1333550NEWT:72407NEWT:352914NEWT:349741NEWT:409859NEWT:157295NEWT:1263871NEWT:509169NEWT:3051137NEWT:9721NEWT:137221NEWT:565050NEWT:409860NEWT:5353NEWT:1034809NEWT:452659NEWT:1193501NEWT:51930NEWT:6689NEWT:298315NEWT:46105NEWT:9704NEWT:1049056NEWT:698936NEWT:1009874NEWT:4498NEWT:8855NEWT:3168NEWT:10185NEWT:521001NEWT:192011NEWT:340912NEWT:1813887NEWT:224911NCBITaxon:11552NEWT:334249NEWT:184922NEWT:6703NEWT:2NEWT:35670NEWT:511693NEWT:4528NEWT:35677NEWT:1493NEWT:10376NEWT:1496NEWT:3674NEWT:660469NEWT:935568NEWT:1365186NEWT:1813019NEWT:45474NEWT:48500NEWT:4513NEWT:5843NEWT:1117645NEWT:376741NCBITaxon:10407NEWT:1000364NEWT:10360NEWT:1403536NEWT:1427524NEWT:47664NEWT:260799NEWT:317548NEWT:3654NEWT:237561NEWT:5833NEWT:3659NEWT:59620NEWT:499229NEWT:31298NEWT:1204162NEWT:82688NEWT:5823NEWT:5821NEWT:44139NCBITaxon:4895NCBITaxon:4896NEWT:675512NEWT:315393NEWT:3649NEWT:28903NEWT:325176NEWT:28909NEWT:3641NEWT:79698NCBITaxon:5796NEWT:12993NEWT:398580NEWT:4565NEWT:1264690NEWT:515619NEWT:170721NEWT:34305NEWT:77020NEWT:83558NEWT:44586NEWT:626528NEWT:139927NEWT:4558NEWT:5888NEWT:431241NEWT:4550NEWT:4555NEWT:144030NEWT:288705NEWT:392815NEWT:3217NEWT:4547NEWT:3218NEWT:556182NEWT:374990NEWT:1432059NEWT:154293NEWT:156471NEWT:3694NEWT:156476NEWT:4543NEWT:210007NEWT:1857017NEWT:10359NEWT:10358NEWT:1735272NEWT:109298NEWT:317513NEWT:580240NEWT:294128NEWT:11676NEWT:1917265NEWT:55210NEWT:718308NEWT:4530NEWT:5861NEWT:1895NEWT:2558360NEWT:215358NEWT:64152NEWT:4924NEWT:2748NEWT:8049NEWT:33892NEWT:99931NEWT:9378NEWT:990346NEWT:100816NEWT:192952NEWT:1640346NCBITaxon:1313NEWT:44544NEWT:529818NEWT:400540NEWT:382NEWT:4911NEWT:152480NEWT:129249NEWT:1077286NEWT:943129NEWT:1221594NEWT:1077281NEWT:1524260NEWT:227321NEWT:281677NEWT:106590NEWT:260710NEWT:4918NEWT:1162296NEWT:106592NEWT:46704NEWT:482428NEWT:1187947NEWT:4903NEWT:10312NCBITaxon:1773NEWT:190304NEWT:1432499NEWT:8030NEWT:246437NEWT:36909NEWT:4909NEWT:443256NEWT:1279365NEWT:759272NEWT:1182263NEWT:943146NEWT:646532NEWT:2711NEWT:537457NEWT:479249NEWT:33889NEWT:10306NEWT:8022NEWT:42353NEWT:593117NEWT:3633NEWT:319761NEWT:3635NEWT:5811NEWT:86662NEWT:180923NEWT:1451NEWT:198215NEWT:200298NEWT:12916NEWT:1400870NEWT:343NEWT:84005NEWT:225117NEWT:8090NEWT:5801NEWT:43665NEWT:5802NEWT:4952NEWT:1266464NEWT:367830NEWT:178616NEWT:95145NEWT:358NEWT:375451NEWT:54788NEWT:357NEWT:74381NEWT:2010198NEWT:457428NEWT:106178NEWT:84023NEWT:559292NEWT:2762NEWT:1174673NEWT:28035NEWT:1313166NCBITaxon:138NEWT:28038NEWT:1422NEWT:1423NEWT:4932NEWT:1205903NEWT:3603NEWT:2756NEWT:2759NEWT:38293NEWT:1428NEWT:339NEWT:2751NEWT:139077NEWT:391904NEWT:12922NEWT:316277NEWT:163159NEWT:1306413NEWT:2813599NEWT:518766NEWT:2664373NEWT:190802NEWT:1213463NEWT:9417NEWT:1216979NEWT:7237NEWT:5059NEWT:31631NEWT:509924NEWT:28450NEWT:115104NEWT:5061NEWT:8570NEWT:127569NEWT:1408434NEWT:1241935NEWT:220668NEWT:9407NEWT:7227NEWT:9402NEWT:415540NEWT:336722NEWT:675060NEWT:416870NEWT:334542NEWT:313625NEWT:51240NEWT:27592NEWT:5052NEWT:227289NEWT:7215NEWT:196139NEWT:651182NEWT:2172103NCBITaxon:59201NEWT:1876254NEWT:434271NEWT:1915NEWT:747679NEWT:66712NEWT:42752NEWT:746360NEWT:89764NEWT:543734NEWT:9870NEWT:435590NEWT:1902NEWT:208526NEWT:1908NEWT:1169740NEWT:216129NEWT:1245012NCBITaxon:38727NEWT:74790NEWT:2829NEWT:126279NEWT:1428006NEWT:62335NEWT:366581NEWT:757417NEWT:216599NEWT:216595NEWT:40559NEWT:51208NEWT:216597NEWT:1607839NEWT:1283300NEWT:1218707NEWT:1204551NEWT:99586NEWT:228577NEWT:392021NEWT:436486NEWT:51655NEWT:1933298NEWT:260707NEWT:121845NEWT:8595NEWT:7263NEWT:186763NEWT:447135NEWT:185431NEWT:216591NEWT:29760NEWT:260704NEWT:703612NEWT:260705NEWT:1202347NEWT:546805NEWT:1505907NEWT:1216981NEWT:1249885NEWT:1972855NEWT:1415167NEWT:36036NEWT:208963NEWT:208964NEWT:181088NEWT:48498NEWT:669202NEWT:6306NEWT:4120NEWT:37334NCBITaxon:10357NCBITaxon:10359NEWT:1203258NEWT:49317NEWT:696811NEWT:9808NEWT:839NEWT:92519NEWT:943925NEWT:4111NEWT:37349NEWT:4113NEWT:837NEWT:640459NEWT:72568NEWT:36015NEWT:51641NEWT:81866NEWT:1262469NEWT:277944NEWT:48479NEWT:61435NEWT:627025NEWT:1097677NEWT:375939NEWT:3258NEWT:112018NEWT:4100NEWT:1159556NEWT:1076NEWT:4102NEWT:1028688NEWT:4101NEWT:6763NEWT:803NEWT:29722NEWT:419947NEWT:2847306NEWT:468911NEWT:13373NEWT:817NEWT:7604NEWT:6756NEWT:818NEWT:135588NEWT:1061NEWT:29719NEWT:6754NEWT:452589NEWT:509068NEWT:4577NEWT:813NEWT:1365218NEWT:1042986NEWT:1911079NEWT:69373NEWT:427577NEWT:264203NEWT:1480154NEWT:9859NEWT:1274414NEWT:2907833NEWT:38626NEWT:10299NEWT:1087439NEWT:61408NEWT:1355477NEWT:90371NEWT:55194NEWT:2907829NEWT:4153NEWT:11137NEWT:278839NEWT:35128NEWT:39966NEWT:7668NEWT:2929635NEWT:915099NEWT:1143193NEWT:1122233NEWT:859313NEWT:59540NEWT:9838NEWT:9839NEWT:546414NEWT:11167NEWT:9835NEWT:7650NEWT:4146NEWT:5478NEWT:6326NEWT:7656NEWT:5476NEWT:5477NEWT:1882945NEWT:746707NEWT:299767NEWT:28835NEWT:1206781NEWT:5480NEWT:1274432NEWT:2053667NEWT:859321NEWT:1274426NEWT:9825NEWT:1274423NEWT:393765NEWT:104421NEWT:39946NEWT:9823NEWT:95602NEWT:314539NEWT:39947NEWT:718274NEWT:1274420NEWT:859314NEWT:578458NEWT:60520